By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.
Atomwise develop AI to help their partners overcome the challenges of drug discovery. Some of their partners are bridgebio, Hansoh, Tulane University, Lilly, Bayer, abbvie, Stempnix etc. Its AI-powered discovery portfolio includes an internally developed pipeline, JVs, academic and biopharma development partners, and is backed by prominent investors.